Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Tirzepatide by Eli Lilly and Co for Obstructive Sleep Apnea: Likelihood of Approval
Tirzepatide is under clinical development by Eli Lilly and Co and currently in Pre-Registration for Obstructive Sleep Apnea. According to...
Data Insights
Tirzepatide by Eli Lilly and Co for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
Tirzepatide is under clinical development by Eli Lilly and Co and currently in Phase II for Metabolic Dysfunction-Associated Steatohepatitis (MASH)....